Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma.
Front Oncol
; 12: 1031944, 2022.
Article
in En
| MEDLINE
| ID: mdl-36338767
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Oncol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland